Central Admixture Pharmacy Services Inc 2023-08-09 Health serious FDA
Health · FDA · Recall #FDA-D-1077-2023
PHENYLephrine in 0.9 sodium chloride, 800 mcg /10 mL, (80 mcg/mL), 10 mL Syringe, Rx… Recall
Issued August 9, 2023 · Central Admixture Pharmacy Services Inc
In August 2023, Central Admixture Pharmacy Services Inc recalled the PHENYLephrine in 0.9 sodium chloride, 800 mcg /10 mL, (80 mcg/mL), 10 mL Syringe, Rx…, a serious health recall reported by the FDA. Affected owners are eligible for a voluntary. Here is what the hazard is and exactly what to do about it.
Compiled by Maya Ellison, RecallCheckr
What this means for you
Lack of assurance of sterility: Lack of validation data for sanitization cycles
What you should do
- 1 Stop using PHENYLephrine in 0.9 sodium chloride, 800 mcg /10 mL, (80 mcg/mL), 10 mL Syringe, Rx… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Central Admixture Pharmacy Services Inc to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Central Admixture Pharmacy Services Inc
- Category
- Health
- Recall date
- August 9, 2023
- Units affected
- Not reported
- Sold at
- Nationwide in the USA
- Recall number
- FDA-D-1077-2023
- Made in
- United States
- Issuing agency
- FDA
In context
- Central Admixture Pharmacy Services Inc has 43 recalls in our database.
- We're tracking 3,576 Health recalls in our database.
- This is the 903rd Health recall we've logged in 2023.